Clinical Trials Browser

Phase NA × Triple Negative Breast Neoplasms × Immunohistochemistry × Clear all

NCT01292083 2014-02-06

Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery

Phase NA Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms